Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:pathogenesis:microbiota:lforms [02.13.2019] – [Future research] sallieqhome:pathogenesis:microbiota:lforms [07.01.2019] – [Future research] sallieq
Line 152: Line 152:
  
 Siobhán M. O'Connor of the Centers for Disease Control and Prevention [[https://wwwnc.cdc.gov/eid/article/12/7/06-0037_article|concurs]], stating, “The epidemiologic, clinical, and pathologic features of many chronic inflammatory diseases are consistent with a microbial cause.” Siobhán M. O'Connor of the Centers for Disease Control and Prevention [[https://wwwnc.cdc.gov/eid/article/12/7/06-0037_article|concurs]], stating, “The epidemiologic, clinical, and pathologic features of many chronic inflammatory diseases are consistent with a microbial cause.”
-===== Future research =====+===== Recent research ===== 
 + 
 +L-form bacteria cohabitants in human blood: significance for health and diseases. (({{pubmed>long:28715646}})) 
 + 
 +==== Future research ==== 
  
 There seems to be little incentive for scientists to study the L-form. Since the bacteria can be killed by simple low-dose antibiotic therapy, drug companies have little interest in investing money into related research. Researchers studying the L-form often find themselves with very little grant money but must still work long, tedious hours in the lab. There seems to be little incentive for scientists to study the L-form. Since the bacteria can be killed by simple low-dose antibiotic therapy, drug companies have little interest in investing money into related research. Researchers studying the L-form often find themselves with very little grant money but must still work long, tedious hours in the lab.
home/pathogenesis/microbiota/lforms.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.